(Press-News.org) MINNEAPOLIS – A new treatment under investigation for multiple sclerosis (MS) is safe and tolerable in phase I clinical trials, according to a study published August 27, 2014, in Neurology® Neuroimmunology & Neuroinflammation, a new online-only, freely accessible, specialty medical journal. The publication is part of the Neurology® family of journals, published by the American Academy of Neurology.
The phase I studies were the first to test the drug candidate in humans. Studies with animals showed that the drug, which is called anti-LINGO-1, or BIIB033, may be able to reverse the demyelination of the nerves. Anti-LINGO-1 blocks LINGO-1, a central nervous system protein that prevents myelination. Current treatments for MS work to reduce new damage to the brain, but do not repair new or past damage.
In MS, the body's immune system begins to attack the myelin that acts as insulation around the nerves in the central nervous system. This makes it more difficult for the nerves to send messages to and from the brain and spinal cord.
In the study, 72 healthy people without MS and 47 people with either relapsing-remitting MS or secondary progressive MS were given the drug or a placebo. The healthy participants received either a placebo or one dose of the drug by an infusion or an injection. The people with MS received either placebo or two intravenous doses of the drug two weeks apart. In both groups, participants received varying amounts of the drug, ranging from 0.1 mg/kg to 100 mg/kg.
The occurrence of side effects was similar for people who received the drug and those who received the placebo. Most side effects were mild to moderate and were not related to the drug. Side effects included headaches, upper respiratory infections and urinary tract infections. There were no serious side effects or deaths.
There were no significant changes in vital signs, EKGs or other safety tests of the drug.
Intravenous doses of 10 mg/kg and higher resulted in concentrations of the drug in the blood that were similar to or higher than the concentration that was associated with 90 percent of the maximum remyelination effect in studies with rats.
"With these results we have been able to start phase II studies to see whether this drug can actually repair the lost myelin in humans and have any effect on restoring physical and cognitive function and improving disability," said study author Diego Cadavid, MD, of Biogen Idec in Cambridge, Mass., which developed the drug. Cadavid is a member of the American Academy of Neurology.
INFORMATION:
The study was supported by Biogen Idec.
Learn more about multiple sclerosis at AAN.com/patients.
The American Academy of Neurology, an association of 28,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, stroke, migraine, multiple sclerosis, brain injury, Parkinson's disease and epilepsy.
For more information about the American Academy of Neurology, visit http://www.aan.com or find us on Facebook, Twitter, Google+ and YouTube.
Researchers investigating new treatment for multiple sclerosis
2014-08-27
ELSE PRESS RELEASES FROM THIS DATE:
Bundled approach to reduce surgical site infections in colorectal surgery
2014-08-27
Bottom Line: A multidisciplinary program (called a "bundle") that spanned the phases of perioperative care helped reduce surgical site infections (SSIs) in patients undergoing colorectal surgery (CRS) at an academic medical center.
Author: Jeffrey E. Keenan, M.D., of the Duke University Medical Center, Durham, N.C., and colleagues.
Background: SSIs are associated with increased complications, length of hospital stay, readmission rates and health care costs. Efforts that have used systematic approaches, called bundles, that aim to incorporate best practices across the ...
Photodynamic therapy vs. cryotherapy for actinic keratoses
2014-08-27
Bottom Line: Photodynamic therapy (PDT, which uses topical agents and light to kill tissue) appears to better clear actinic keratoses (AKs, a common skin lesion caused by sun damage) at three months after treatment than cryotherapy (which uses liquid nitrogen to freeze lesions).
Author: Gayatri Patel, M.D., M.P.H., of the University of California Davis Medical Center, in Sacramento, and colleagues.
Background: AKs are rough, scaly lesions on the skin typically found on individuals with fair complexions who have had lots of sun exposure. The lesions have the potential ...
APOE, diagnostic accuracy of CSF biomarkers for Alzheimer disease
2014-08-27
Bottom Line: Cerebral spinal fluid (CSF) levels of β-amyloid 42(Aβ42) are associated with the diagnosis of Alzheimer disease (AD) and (Aβ) accumulation in the brain independent of apolipoprotein E (APOE) gene makeup.
Authors: Ronald Lautner, M.D., of Sahlgrenska University Hospital, Sweden, and colleagues.
Background: With the emergence of biomarker dementia diagnostics, interest in CSF biomarkers associated with AD, including Aβ42 and tau proteins, is increasing. The APOE gene is the most prominent susceptibility gene for late-onset AD. For the ...
NASA's TRMM Satellite sees powerful towering storms in Cristobal
2014-08-27
VIDEO:
NASA's TRMM Satellite Sees Powerful Towering Storms in Cristobal On Aug. 26, NASA's TRMM Satellite saw a band of thunderstorms with heights of over 15km (about 9.3 miles) and was...
Click here for more information.
NASA's TRMM satellite identified areas of heavy rainfall occurring in Hurricane Cristobal as it continued strengthening on approach to Bermuda.
NASA's Tropical Rainfall Measuring Mission or TRMM satellite flew above Hurricane Cristobal on August 26 at 11:35 ...
Experiments explain why some liquids are 'fragile' and others are 'strong'
2014-08-27
Only recently has it become possible to accurately "see" the structure of a liquid. Using X-rays and a high-tech apparatus that holds liquids without a container, Kenneth Kelton, PhD, the Arthur Holly Compton Professor in Arts & Sciences at Washington University in St. Louis, was able to compare the behavior of glass-forming liquids as they approach the glass transition.
The results, published in the August 6 issue of Nature Communications, are the strongest demonstration yet that bulk properties of glass-forming liquids, such as viscosity, are linked to microscopic ...
Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices
2014-08-27
TALLAHASSEE, Fla. — Exciting new work by a Florida State University research team has led to a novel molecular system that can take your temperature, emit white light, and convert photon energy directly to mechanical motions.
And, the molecule looks like a butterfly.
Biwu Ma, associate professor in the Department of Chemical and Biomedical Engineering in the FAMU-FSU College of Engineering, created the molecule in a lab about a decade ago, but has continued to discover that his creation has many other unique capabilities.
For example, the molecular butterfly can flap ...
A touching story: The ancient conversation between plants, fungi and bacteria
2014-08-27
MADISON, Wis. — The mechanical force that a single fungal cell or bacterial colony exerts on a plant cell may seem vanishingly small, but it plays a heavy role in setting up some of the most fundamental symbiotic relationships in biology. In fact, it may not be too much of a stretch to say that plants may have never moved onto land without the ability to respond to the touch of beneficial fungi, according to a new study led by Jean-Michel Ané, a professor of agronomy at the University of Wisconsin-Madison.
"Many people have studied how roots progress through the soil, ...
Protein in 'good cholesterol' may be a key to treating pulmonary hypertension
2014-08-27
Oxidized lipids are known to play a key role in inflaming blood vessels and hardening arteries, which causes diseases like atherosclerosis. A new study at UCLA demonstrates that they may also contribute to pulmonary hypertension, a serious lung disease that narrows the small blood vessels in the lungs.
Using a rodent model, the researchers showed that a peptide mimicking part of the main protein in high-density lipoprotein (HDL), the so-called "good" cholesterol, may help reduce the production of oxidized lipids in pulmonary hypertension. They also found that reducing ...
Research geared to keep women from fleeing IT profession
2014-08-27
WACO, Texas (August 27, 2014) – For years, employers and experts have been trying to reverse the exodus of women from information technology positions.
They're failing.
Studies show that women are significantly underrepresented in the IT field, and the number of women who've graduated with degrees in computer and information science have plummeted from 37 percent in 1985 to 18 percent in 2011.
The failure to "stop the bleeding" stems, in part, from the industry's reliance on an oft-cited, outdated and under-studied research model, said Cindy Riemenschneider, Ph.D., ...
No cookie-cutter divorces, so what info should online co-parenting classes offer?
2014-08-27
URBANA, Ill. – Required online classes for divorcing couples who have children are good at teaching parents how to deal with children's needs and responses to their family's new situation. But co-parenting couples would benefit from content that helps adults cope with their own emotions and from unique tracks for families with special circumstances such as intimate partner violence or alcoholism, said a University of Illinois researcher in human and community development.
"There is no cookie-cutter divorcing couple, and with online programming, educators are able to supply ...